New Haven, CT · Founded 2018 · Privately Held (backing)
Developer of a therapeutic drug designed to reverse neurodegeneration. Allyx Therapeutics is based in New Haven, CT and was founded in 2018. Its last reported valuation was $32.3 million in Feb 2023. It has raised $13.2 million across 4 recorded rounds; the latest was a $26.4 million early-stage round in May 2026.
Last reported valuation
$32.3M
Oct 2026
Priced at
—
Total raised
$13.2M
Last round
Early Stage VC
May 2026
Cap table — not yet on record
Allyx Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Allyx Therapeutics with a free account
·Watch Allyx Therapeutics: the Monday email on marks, rounds and moves
Where does Allyx Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Allyx Therapeutics's 4 recorded funding rounds.
